In development: Guidance, quality standards and advice
Showing 1 to 7 of 7
| Title | Type | Expected publication date |
|---|---|---|
| Drug-eluting coronary stents for treating coronary artery disease: late-stage assessment | Health technology evaluation | |
| Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over [ID1651] | Technology appraisal guidance | TBC |
| Intrapartum care - uterotonics for postpartum haemorrhage | NICE guideline | |
| Molnupiravir for treating COVID 19 [ID6340] | Technology appraisal guidance | |
| Pegcetacoplan for treating geographic atrophy [ID4041] | Technology appraisal guidance | TBC |
| Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer [ID6461] | Technology appraisal guidance | TBC |
| Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease [ID3821] | Technology appraisal guidance |